NorthWest Biotherapeutics Inc (NWBO)

[meirluc]

If Keytruda's falling of the patent cliff could be remedied for example
by treating patients with viral vaccines whose potency has been shown
to be greatly increased by a co-administration of keytruda, a large
financial investment by Merck to manufacture those modified vaccines would
seem extremely logical. If someone is aware of that potentially successful
vaccine combo, please let us know.

OTOH at this point, there probably is convincing evidence that keytruda potentiates
the activity of DCVax-L. We cannot know how much of Merck's present expansion
efforts and finances would be dedicated to develop the marketing of this combo vaccine
but it is one tangible possibility that makes sense whereas completely dismissing
this possibility does not IMHO.